Fresenius Medical Care Q2 FY26 operating income excluding special items rises 23% to EUR 569 million; revenue increases 4% to EUR 4.86 billion
FMS•Q2 operating income beats consensus
Fresenius Medical Care posted Q2 2026 operating income excluding special items of EUR 569 million, up 23% from a year earlier.
That result topped the market consensus of EUR 515 million, helped by stronger-than-expected growth in the Care Delivery segment.
Revenue rises and full-year outlook is unchanged
Revenue rose 4% to EUR 4.86 billion, slightly ahead of the EUR 4.79 billion consensus estimate.
The group confirmed its unchanged full-year 2026 outlook.
